For private equity transactions going forward during the COVID-19 crisis, and for those occurring several years after it’s over, private equity investors will need to perform additional due diligence to evaluate whether and how well targets managed compliance during the pandemic. In particular, investors will need to determine if targets have properly relied on and implemented numerous regulatory waivers and other changes that CMS and other federal and state regulators issued in response to the pandemic. Evaluating compliance with numerous regulatory changes occurring at lightning speed during the pandemic and the transition back to post-COVID 19 requirements will be a high priority for investors evaluating potential targets for private equity investment.
Read the full article: COVID-19 Update: The Impact of COVID-19 on Health Care Private Equity Due Diligence //
Source: https://www.jdsupra.com/legalnews/covid-19-update-the-impact-of-covid-19-18986